1. Home
  2. STXS vs HEQ Comparison

STXS vs HEQ Comparison

Compare STXS & HEQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • HEQ
  • Stock Information
  • Founded
  • STXS 1990
  • HEQ 2011
  • Country
  • STXS United States
  • HEQ United States
  • Employees
  • STXS N/A
  • HEQ N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • HEQ Investment Managers
  • Sector
  • STXS Health Care
  • HEQ Finance
  • Exchange
  • STXS Nasdaq
  • HEQ Nasdaq
  • Market Cap
  • STXS 151.3M
  • HEQ 127.8M
  • IPO Year
  • STXS 2004
  • HEQ N/A
  • Fundamental
  • Price
  • STXS $2.48
  • HEQ $10.58
  • Analyst Decision
  • STXS
  • HEQ
  • Analyst Count
  • STXS 0
  • HEQ 0
  • Target Price
  • STXS N/A
  • HEQ N/A
  • AVG Volume (30 Days)
  • STXS 712.8K
  • HEQ 43.1K
  • Earning Date
  • STXS 08-07-2025
  • HEQ 01-01-0001
  • Dividend Yield
  • STXS N/A
  • HEQ 9.78%
  • EPS Growth
  • STXS N/A
  • HEQ N/A
  • EPS
  • STXS N/A
  • HEQ N/A
  • Revenue
  • STXS $31,806,000.00
  • HEQ N/A
  • Revenue This Year
  • STXS $29.03
  • HEQ N/A
  • Revenue Next Year
  • STXS $44.05
  • HEQ N/A
  • P/E Ratio
  • STXS N/A
  • HEQ N/A
  • Revenue Growth
  • STXS 33.94
  • HEQ N/A
  • 52 Week Low
  • STXS $1.54
  • HEQ $9.08
  • 52 Week High
  • STXS $2.72
  • HEQ $11.84
  • Technical
  • Relative Strength Index (RSI)
  • STXS 59.23
  • HEQ 54.29
  • Support Level
  • STXS $2.18
  • HEQ $10.36
  • Resistance Level
  • STXS $2.67
  • HEQ $10.68
  • Average True Range (ATR)
  • STXS 0.14
  • HEQ 0.07
  • MACD
  • STXS -0.00
  • HEQ 0.00
  • Stochastic Oscillator
  • STXS 66.07
  • HEQ 68.75

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

About HEQ John Hancock Hedged Equity & Income Fund of Beneficial Interest

John Hancock Hedged Equity & Income Fund is a closed-end management investment company. Its investment objective is to provide total return with a focus on current income and gains and also consisting of long-term capital appreciation. It invests in various sectors such as financials, consumer discretionary, information technology, energy, healthcare, materials, real estate, consumer staples, short-term investments, and others.

Share on Social Networks: